Basel Medical Group (BMGL) Competitors $1.98 +0.08 (+4.21%) As of 08/22/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BMGL vs. NAKA, EUDA, KDLY, QIPT, SERA, BNR, CORBF, ATPC, BDSX, and PIIIShould you be buying Basel Medical Group stock or one of its competitors? The main competitors of Basel Medical Group include KindlyMD (NAKA), EUDA Health (EUDA), Kindly MD (KDLY), Quipt Home Medical (QIPT), Sera Prognostics (SERA), Burning Rock Biotech (BNR), Global Cord Blood (CORBF), Agape ATP (ATPC), Biodesix (BDSX), and P3 Health Partners (PIII). These companies are all part of the "healthcare" industry. Basel Medical Group vs. Its Competitors KindlyMD EUDA Health Kindly MD Quipt Home Medical Sera Prognostics Burning Rock Biotech Global Cord Blood Agape ATP Biodesix P3 Health Partners Basel Medical Group (NASDAQ:BMGL) and KindlyMD (NASDAQ:NAKA) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability. Is BMGL or NAKA more profitable? Basel Medical Group has a net margin of 0.00% compared to KindlyMD's net margin of -244.00%. Basel Medical Group's return on equity of 0.00% beat KindlyMD's return on equity.Company Net Margins Return on Equity Return on Assets Basel Medical GroupN/A N/A N/A KindlyMD -244.00%-131.09%-106.04% Which has higher earnings and valuation, BMGL or NAKA? Basel Medical Group has higher earnings, but lower revenue than KindlyMD. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBasel Medical GroupN/AN/AN/AN/AN/AKindlyMD$2.72M1,400.77-$3.62M-$0.86-11.78 Does the media favor BMGL or NAKA? In the previous week, KindlyMD had 1 more articles in the media than Basel Medical Group. MarketBeat recorded 3 mentions for KindlyMD and 2 mentions for Basel Medical Group. KindlyMD's average media sentiment score of -0.02 beat Basel Medical Group's score of -0.50 indicating that KindlyMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Basel Medical Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative KindlyMD 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryBasel Medical Group and KindlyMD tied by winning 3 of the 6 factors compared between the two stocks. Get Basel Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BMGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BMGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BMGL vs. The Competition Export to ExcelMetricBasel Medical GroupMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.06M$7.70B$5.76B$9.58BDividend YieldN/A2.71%4.41%4.09%P/E RatioN/A78.4731.1026.05Price / SalesN/A49.18436.12105.98Price / CashN/A24.6737.7358.48Price / BookN/A24.799.536.61Net IncomeN/A$243.33M$3.26B$265.56M7 Day Performance0.51%1.08%2.11%1.98%1 Month Performance-13.54%0.80%5.12%1.33%1 Year PerformanceN/A13.93%31.25%21.15% Basel Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BMGLBasel Medical GroupN/A$1.98+4.2%N/AN/A$35.06MN/A0.0036Lockup ExpirationGap DownNAKAKindlyMDN/A$13.67-9.0%N/AN/A$104.03M$2.72M-15.90N/ANews CoverageGap DownEUDAEUDA HealthN/A$2.54-2.3%N/A-43.8%$94.39M$4.01M0.002Gap UpKDLYKindly MDN/A$15.02+13.4%N/A+525.3%$90.45M$2.47M-19.51N/APositive NewsQIPTQuipt Home Medical3.3543 of 5 stars$2.04+2.5%$2.85+39.7%-21.8%$88.62M$245.91M-8.501,200Analyst ForecastSERASera Prognostics1.0914 of 5 stars$2.25flatN/A-66.3%$84.76M$80K-2.65120News CoveragePositive NewsBNRBurning Rock Biotech0.3651 of 5 stars$7.48+7.6%N/A+45.3%$80.49M$70.67M-3.961,390Upcoming EarningsGap DownCORBFGlobal Cord BloodN/A$0.55flatN/A+53.5%$66.85M$196.12M0.001,200ATPCAgape ATP0.2569 of 5 stars$1.26+4.1%N/A-32.5%$63.01M$1.32M-3.0740News CoverageShort Interest ↑Gap DownBDSXBiodesix2.9939 of 5 stars$0.40-0.2%$1.75+341.6%-74.2%$58.11M$71.32M-1.37220PIIIP3 Health Partners2.2946 of 5 stars$6.78-2.3%$16.25+139.7%-70.8%$48.75M$1.50B-0.14500Short Interest ↑ Related Companies and Tools Related Companies NAKA Alternatives EUDA Alternatives KDLY Alternatives QIPT Alternatives SERA Alternatives BNR Alternatives CORBF Alternatives ATPC Alternatives BDSX Alternatives PIII Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BMGL) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Basel Medical Group Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Basel Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access